ConductScience.org, home

Paper17567740

Functional structure of the somatomedin B domain of vitronectin.

Zhou A. Protein Sci, 2007. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Functional structure of the somatomedin B domain of vitronectin. Papers, record 17567740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17567740

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Functional structure of the somatomedin B domain of vitronectin.
PubMed
Journal
Protein Sci
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou AAiwu

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SomatomedinsMajor topic
VitronectinMajor topic
Amino Acid Sequence
Animals
Chromatography, Liquid
Cyanogen Bromide
Cysteine
Disulfides
Drosophila
Humans
Mass Spectrometry
Mice
Molecular Sequence Data
Plasminogen Activator Inhibitor 1
Protein Binding
Protein Denaturation
Protein Structure, Secondary
Protein Structure, Tertiary
Rats
Sequence Homology, Amino Acid
Structure-Activity Relationship

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112067733The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand.FEBS Lett2002https://conductscience.org/library/papers/12067733PubMed
211792750Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.J Natl Cancer Inst2002https://conductscience.org/library/papers/11792750PubMed
312437099Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.Biol Chem2002https://conductscience.org/library/papers/12437099PubMed
412461559uPAR: a versatile signalling orchestrator.Nat Rev Mol Cell Biol2002https://conductscience.org/library/papers/12461559PubMed
512808446How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration.Nat Struct Biol2003https://conductscience.org/library/papers/12808446PubMed
612840147Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12840147PubMed
714706846Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal.FEBS Lett2004https://conductscience.org/library/papers/14706846PubMed
814963029Conservation of critical functional domains in murine plasminogen activator inhibitor-1.J Biol Chem2004https://conductscience.org/library/papers/14963029PubMed
915157085Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.Biochemistry2004https://conductscience.org/library/papers/15157085PubMed
1015123712The solution structure of the N-terminal domain of human vitronectin: proximal sites that regulate fibrinolysis and cell migration.J Biol Chem2004https://conductscience.org/library/papers/15123712PubMed
1115173163Assignment of the four disulfides in the N-terminal somatomedin B domain of native vitronectin isolated from human plasma.J Biol Chem2004https://conductscience.org/library/papers/15173163PubMed
1215379715Plasminogen activator inhibitor-1.Curr Med Chem2004https://conductscience.org/library/papers/15379715PubMed
132930999Plasminogen activators, tissue degradation, and cancer.Adv Cancer Res1985https://conductscience.org/library/papers/2930999PubMed
142459123Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).J Biol Chem1988https://conductscience.org/library/papers/2459123PubMed
152460263Novel purification of vitronectin from human plasma by heparin affinity chromatography.Cell Struct Funct1988https://conductscience.org/library/papers/2460263PubMed
162462509Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma.FEBS Lett1988https://conductscience.org/library/papers/2462509PubMed
172463252Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin.J Biol Chem1989https://conductscience.org/library/papers/2463252PubMed
182467912Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin.J Biol Chem1989https://conductscience.org/library/papers/2467912PubMed
191696502Complex formation between plasminogen activator inhibitor 1 and vitronectin in purified systems and in plasma.Biochim Biophys Acta1990https://conductscience.org/library/papers/1696502PubMed
202211644Plasma cell membrane glycoprotein PC-1. cDNA cloning of the human molecule, amino acid sequence, and chromosomal location.J Biol Chem1990https://conductscience.org/library/papers/2211644PubMed

See all 42 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42358585Vitronectin-GM-CSF fusion protein hydrogel with a recruitment-anchoring-activation strategy accelerates vascularized tissue regeneration.Regen Biomater2026https://conductscience.org/library/papers/42358585PubMed
41302824Comprehensive Analysis of Cathepsin Genes in Hemiptera: Functional Characterization of the Venomous Cathepsin B from Sycanus bifidus.Insects2025https://conductscience.org/library/papers/41302824PubMed
39065153Recruitment of Vitronectin by Bacterial Pathogens: A Comprehensive Overview.Microorganisms2024https://conductscience.org/library/papers/39065153PubMed
32695935Insight into vitronectin structural evolution on material surface chemistries: The mediation for cell adhesion.Bioact Mater2020https://conductscience.org/library/papers/32695935PubMed
31793295Characterization of an Extensive Interface on Vitronectin for Binding to Plasminogen Activator Inhibitor-1: Adoption of Structure in an Intrinsically Disordered Region.Biochemistry2019https://conductscience.org/library/papers/31793295PubMed
31682300Identification of a PAI-1-binding site within an intrinsically disordered region of vitronectin.Protein Sci2020https://conductscience.org/library/papers/31682300PubMed
31092842The involvement of autotaxin in renal interstitial fibrosis through regulation of fibroblast functions and induction of vascular leakage.Sci Rep2019https://conductscience.org/library/papers/31092842PubMed
29663255Structural Characterization and Disulfide Assignment of Spider Peptide Phα1β by Mass Spectrometry.J Am Soc Mass Spectrom2018https://conductscience.org/library/papers/29663255PubMed
28603747Vitronectin in the ascites of human ovarian carcinoma acts as a potent chemoattractant for ovarian carcinoma: Implication for metastasis by cancer stem cells.J Cancer Stem Cell Res2016https://conductscience.org/library/papers/28603747PubMed
28086938Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.J Hematol Oncol2017https://conductscience.org/library/papers/28086938PubMed
27828845Early effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysis.Medicine (Baltimore)2016https://conductscience.org/library/papers/27828845PubMed
27634880
Evidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: a novel view of the metastasis of cancer cells to low-fibrinogen lymphatics and body cavities.
Oncotarget2016https://conductscience.org/library/papers/27634880PubMed
25977291Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.J Lipid Res2016https://conductscience.org/library/papers/25977291PubMed
21240271Structural basis of substrate discrimination and integrin binding by autotaxin.Nat Struct Mol Biol2011https://conductscience.org/library/papers/21240271PubMed
18689689PAI-1 inhibits neutrophil efferocytosis.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18689689PubMed
18658131Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domain.J Biol Chem2008https://conductscience.org/library/papers/18658131PubMed
18174166A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity.J Biol Chem2008https://conductscience.org/library/papers/18174166PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene
VTN7448PubTator's text mininghttps://conductscience.org/library/genes/7448NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17567740

GET https://conductscience.org/api/papers/v1/17567740/references?page=2